Some side effects when taking Rybelsus include a decrease in appetite, vomiting, consistent burping, constipation, and abdominal pain
Tirzepatide/Mounjaro already has FDA approval for diabetes, and it now has two global phase 3 clinical trials supporting its potential for weight loss, following even stronger SURMOUNT-1 results among non-diabetic patients (up to 22% weight loss)
Both peptides chelate copper in a 1:1 ratio, but GHK-Cu shows stronger evidence for fibroblast activation at concentrations between 110 micromolar in cell culture models, which translates to approximately 0.52.0% in topical formulations
Acid production is maintained, intrinsic factor is unaffected, and the absorption pathway stays intact
Planning ahead is the point
Aim for at least 8 to 10 glasses of filtered water a day to help flush out the toxins that glutathione neutralizes